ESCI期刊Clinical Advances in Hematology & Oncology 2024/2025影响因子:1.154 (CLIN ADV HEMATOL ONC) (1543-0790). (ONCOLOGY)(肿瘤学

显示全部楼层 · 发表于 2025-3-23 10:11:00

Submitted on: 17 February 2019. Revised on: 04 April 2019. Accepted on: 10 May 2019. ___________________Clinical Advances in Hematology & Oncology

显示全部楼层 · 发表于 2025-3-23 17:06:17

显示全部楼层 · 发表于 2025-3-23 18:16:11

显示全部楼层 · 发表于 2025-3-23 22:29:15

显示全部楼层 · 发表于 2025-3-24 03:45:19

Submitted on: 13 January 2012. Revised on: 12 May 2012. Accepted on: 25 June 2012. ___________________Clinical Advances in Hematology & Oncology

显示全部楼层 · 发表于 2025-3-24 06:33:59

显示全部楼层 · 发表于 2025-3-24 12:17:03

Submitted on: 03 May 2011. Revised on: 26 July 2011. Accepted on: 29 August 2011. ___________________Clinical Advances in Hematology & Oncology

显示全部楼层 · 发表于 2025-3-24 18:13:48

显示全部楼层 · 发表于 2025-3-24 20:06:14

Submitted on: 22 December 2006. Revised on: 30 March 2007. Accepted on: 28 April 2007. ___________________Clinical Advances in Hematology & Oncology

显示全部楼层 · 发表于 2025-3-25 01:41:47

Submitted on: 09 April 2005. Revised on: 01 August 2005. Accepted on: 25 August 2005. ___________________Clinical Advances in Hematology & Oncology

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 16:49
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved